Orthopedic Surgeon Blasts Vioxx® and COX-2 Inhibitors

Share Article

MD says, �I lost a parent to Vioxx®.�

A Toronto-based medical doctor, and orthopedic surgeon, Dr. Kamille Ramsundar, blasted Merck & Co’s Vioxx® and the entire class of COX-2 inhibitors, including Celebrex®, in a taped telephone interview with StockInterview.com. Dr. Ramsundar said, “Vioxx® is a medication that I knew all along that would have given, and would have had, problems. All of the clinical studies have shown that it affects the renal area. As I have indicated previously, it is something very close to my heart because I had a lost a parent, who used Vioxx® extensively. Even with all the warnings, it was still prescribed to him. He took it. The immediate relief was there, but the long term impact on the body itself and the renal system was irreversible… Vioxx® is not going to come back on the market right away. It will take quite a few years.”

Dr. Ramsundar, also with the Canadian Institute of Orthopaedics, also criticized Pfizer’s Celebrex®, saying: “I feel very much the same way about Celebrex® as I feel about Vioxx®. All of the questions that are being asked right now are the same questions of Vioxx®. What are the symptoms? Nobody seems to be able to tell you. What is the long-term impact? I think we all know what that impact will be. It does affect the renal system.”

Dr. Ramsundar recently announced that he endorses the O24® product, an all natural pain relief topical analgesic as an alternative to COX-2 Inhibitors and NSAIDs. The entire interview can be viewed at: http://www.stockinterview.com/swiss-medica-ramsundar.html

The patented and clinically tested pain relief alternative, manufactured by Swiss Medica delivers up to four hours of pain remission, lacking the side effects found with pain pills. The O24® Essential Oil Pain Neutralizer is now being sold in leading Canadian pharmacies and natural food stores, anticipating US distribution later this year. The pain relief product has been in wide distribution among European ski, skating and track teams for a number of years.

All Trademarks Respected.

(Source: StockInterview.com)

For More Information

Contact Blue Skye PR, Inc

Sky Wallen: 813-732-6869

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sky Wallen
Visit website